<DOC>
	<DOC>NCT00379730</DOC>
	<brief_summary>Prednisolone will be used as a model medication to identify new clinical outcomes for future evaluation of new therapies in short-term studies (up to 4 weeks) in patients with Chronic Obstructive Pulmonary Disease (COPD).</brief_summary>
	<brief_title>Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>An established clinical history of COPD Evidence of bronchitis Current or exsmoker COPD exacerbation requiring steroid and/or antibiotics in the last month Taking oral or inhaled steroids for more than 14 days in the last 6 months Unable to withhold salbutamol/albuterol for a 6 hour period History of alcohol, substance or drug abuse within the last year. Other significant medical condition e.g. diabetes Cancer that has not been in complete remission for at least 5 years As a result of the medical interview, physical examination or screening investigations, that the doctor considers the subject unfit for the study.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>CT scan</keyword>
	<keyword>breathing tests</keyword>
	<keyword>lung function tests</keyword>
	<keyword>biomarkers</keyword>
	<keyword>prednisolone</keyword>
	<keyword>IOS</keyword>
	<keyword>COPD</keyword>
	<keyword>clinical outcomes</keyword>
</DOC>